# Aerobic exercise inhibits oxidative stress and improves diabetic cardiomyopathy in rats by activating the PROC/PAR1/Nrf2/HO-1 signaling pathway

**Authors:** Sicong Xie, Cheng Chang, Thi Mai Tran, Zhiyi Zhou, Chenshuo Yu, Yucheng Chen, Jiayin Lin, Jiaxuan Xu, Lei Wang, Yang Zhang

PMC · DOI: 10.3389/fphys.2026.1727186 · Frontiers in Physiology · 2026-01-29

## TL;DR

Aerobic exercise helps reduce heart damage in diabetic rats by activating a specific signaling pathway that fights oxidative stress.

## Contribution

The study identifies a novel signaling pathway (PROC/PAR1/Nrf2/HO-1) through which aerobic exercise improves diabetic cardiomyopathy.

## Key findings

- Aerobic exercise improved heart function and reduced oxidative stress in diabetic rats.
- The PROC/PAR1/Nrf2/HO-1 pathway was activated by aerobic exercise and linked to reduced heart damage.
- Nine hub genes were identified, with PROC being the only one showing consistent changes with exercise.

## Abstract

Diabetic cardiomyopathy (DCM) is a serious complication of end-stage diabetes that manifests as cardiac hypertrophy and heart failure. The present study performed a bioinformatics analysis to predict possible targets for aerobic exercise to improve DCM, and animal experiments were conducted to detect the relevant mechanisms. Oxidative stress (OS)-DCM-trained differentially expressed genes (DEGs) were retrieved from the GeneCards database and a Gene Expression Omnibus microarray dataset. Subsequently, a protein-protein interaction network was constructed to screen the hub genes of the OS-DCM-trained DEGs. In addition, a model of type 2 diabetes was established using streptozotocin and a high-fat diet. Rats were divided into the control, DCM and DCM plus exercise (DCME) groups. The DCME group underwent 8 weeks of moderate-intensity treadmill training. Assessment of cardiac function, myocardial enzymes and OS-related indicators in each group. Compared with the control group, the levels of BNP, CK-MB, c-TnT, LDH, MDA, LVEF, LVIDd, and LVIDs in the DCM group were significantly increased (P < 0.05), while SOD, GSH, and LVFS were significantly decreased (P < 0.05); The above indicators were significantly improved in DCME group rats (P < 0.05). In addition, the expression levels of target genes predicted to be associated with the aerobic exercise-induced improvement of DCM were detected and western blotting was used to determine the relevant signaling pathways. Bioinformatics analysis identified nine hub genes, which, according to Kyoto Encyclopedia of Genes and Genomes enrichment analysis, were mainly involved in “IL-17 signaling pathway,” “TNF signaling pathway,” “apoptosis” and “necroptosis.” Aerobic exercise improved the heart function and myocardial enzymes of the rats in the DCM group, reduced myocardial damage, and inhibited fibrosis and OS. Detection of the nine core genes revealed that only protein C (PROC) met the predicted trend; PROC expression was lower in the DCM group than that in the control group and was higher in the DCME group than that in the DCM group (P < 0.05). Further confirmation using western blotting suggested that aerobic exercise may improve DCM by activating the PROC/proteinase-activated receptor 1 (PAR1)/nuclear factor (erythroid-derived 2)-like 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling pathway. In conclusion, aerobic exercise may mitigate DCM by activating the PROC/PAR1/Nrf2/HO-1 signaling pathway. These findings could pave the way for further investigations into how exercise might regulate OS and influences DCM progression, providing novel insights into its diagnosis and prognosis.

## Linked entities

- **Genes:** PROC (protein C, inactivator of coagulation factors Va and VIIIa) [NCBI Gene 5624], MARK2 (microtubule affinity regulating kinase 2) [NCBI Gene 2011], GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551], HMOX1 (heme oxygenase 1) [NCBI Gene 3162]
- **Chemicals:** streptozotocin (PubChem CID 29327)
- **Diseases:** type 2 diabetes (MONDO:0005148)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Nppb (natriuretic peptide B) [NCBI Gene 25105] {aka BNP, Bnf}, Tnnt2 (troponin T2, cardiac type) [NCBI Gene 24837] {aka CTTG, Ctt, RATCTTG, Tnnt3}, Nfe2l2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 83619], Proc (protein C, inactivator of coagulation factors Va and VIIIa) [NCBI Gene 25268], Hmox1 (heme oxygenase 1) [NCBI Gene 24451] {aka HEOXG, Heox, Hmox, Ho-1, Ho1, hsp32}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, Il17a (interleukin 17A) [NCBI Gene 301289] {aka CTLA-8, IL-17, IL-17A, Il17}, F2r (coagulation factor II (thrombin) receptor) [NCBI Gene 25439] {aka Par1, TRGPC}
- **Diseases:** type 2 diabetes (MESH:D003924), heart failure (MESH:D006333), myocardial damage (MESH:D009202), cardiac hypertrophy (MESH:D006332), fibrosis (MESH:D005355), DCM (MESH:D058065), end-stage diabetes (MESH:D007676)
- **Chemicals:** streptozotocin (MESH:D013311), MDA (MESH:D015104)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12898814/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12898814/full.md

## References

72 references — full list in the complete paper: https://tomesphere.com/paper/PMC12898814/full.md

---
Source: https://tomesphere.com/paper/PMC12898814